| Model |
R |
R2 |
ΔR2 |
ΔF |
df |
β |
| Step 1: Immune status |
0.01 |
<0.01 |
<0.01 |
0.16 |
1,99 |
|
| CD4cell count |
|
|
|
|
|
-0.13 |
| Step 2: Disease status |
0.03 |
<0.01 |
<0.01 |
0.10 |
2,98 |
|
| CD4cell count |
|
|
|
|
|
-0.02 |
| Viral load |
|
|
|
|
|
-0.03 |
| Step 3: Demographic |
0.22 |
0.05 |
0.05 |
1.12 |
5,94 |
|
| CD4cell count |
|
|
|
|
|
-0.05 |
| Viral load |
|
|
|
|
|
-0.06 |
| Age |
|
|
|
|
|
-0.07 |
| Gender |
|
|
|
|
|
0.19 |
| Race (Black) |
|
|
|
|
|
-0.06 |
| Race (White) |
|
|
|
|
|
-0.08 |
| Step 4: Baseline Adherence |
0.62 |
0.38 |
0.34 |
50.31 |
7,93 |
|
| CD4cell count |
|
|
|
|
|
-0.05 |
| Viral load |
|
|
|
|
|
0.03 |
| Age |
|
|
|
|
|
-0.06 |
| Gender |
|
|
|
|
|
0.08 |
| Race (Black) |
|
|
|
|
|
0.11 |
| Race (White) |
|
|
|
|
|
-0.03 |
| Medication adherence at baseline |
|
|
|
|
|
-0.60*** |
| Step 5: Active patient involvement |
0.65 |
0.42 |
0.04 |
5.65 |
8,92 |
|
| CD4cell count |
|
|
|
|
|
-0.08 |
| Viral load |
|
|
|
|
|
0.05 |
| Age |
|
|
|
|
|
-0.03 |
| Gender |
|
|
|
|
|
0.07 |
| Race (Black) |
|
|
|
|
|
0.11 |
| Race (White) |
|
|
|
|
|
-0.01 |
| Medication adherence at baseline |
|
|
|
|
|
-0.62*** |
| Active patient involvement |
|
|
|
|
|
0.20* |
|
